Neuralstem, Inc. announced that final data on the intraspinal delivery method employed in its NSI-566 Phase I trial to treat amyotrophic lateral sclerosis was presented today at the American Association of Neurological Surgeons Annual Meeting.
http://www.freshnews.com/news/790978/neuralstem-als-trial-data-presented-at-the-american-association-of-neurological-surgeon
http://www.freshnews.com/news/790978/neuralstem-als-trial-data-presented-at-the-american-association-of-neurological-surgeon
No comments:
Post a Comment